Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Clinical Research - Head For A Carried Out-In-India Tag

Released on = September 14, 2006, 10:15 pm

Press Release Author = RNCOS

Industry = Pharmaceuticals

Press Release Summary = In the run to catch the fancy of global drug makers as a
fitting destination for clinical research, India demonstrates the potential to
stalemate the dragon land. And India\'s advantage lies right in her genes.

Press Release Body = India has an enriched pool of English educated, highly
qualified and skilled medical professionals, suited for R &D activities. The large
Indian populace serves as a perfect sample space for studying the impact of diseases
in the backdrop of the marginal exposure to healthcare facilities.

India is also home to a heterogeneous blend of different gene types like Caucasians,
Australoids and Mogoloids. Drug companies are interested to use this microcosm for
testing the impact of new drugs.

In the present scenario, globally the total size of outsourced clinical trails in
the Pharmaceutical market stands at US$221 billion. This market is growing at an
annual growth rate, ranging between 9-11 %. India accounts for a major chunk of this
market standing at US$285 million.


The market research report, “Opportunities in Indian Pharma Sector”, by
RNCOS finds that India is fast assuming the position of the most favored destination
for clinical trials. The raison d’etre is cost cutting for competitive edge.

The estimated size of clinical trial conducted in India, whether directly or through
research organizations in the Pharmaceutical market is projected to stand at US$ 2
billion by 2010.

The research report also addresses the issues and facts that are critical to
business success, like:

- What are the emerging trends in the Pharmaceutical sector in India?
- What are the key regulations and the policy environment in the industry?
- What are the future trends of the Pharmaceutical market in India?
- Who are the Key players in the Pharmaceutical Market in India?
- What are the Opportunities and Threats in pharmaceuticals sector?
- How is the market affected by other factors prevailing in the economy?

The report incorporates detailed data and analysis that will help investors and
business heads to comprehend the changing dynamics of the Pharmaceutical market in
India.

About RNCOS:

RNCOS, incorporated in 2002, provides Market Research Reports for your business
needs and aims to put an end to your information pursuit. Our expertise in gathering
global business information for industry research, corporate training, growth
consulting, and business consulting, brings reputed companies and firms to us for
business enhancement solutions. We can be your one-stop-shop for Industry research
information and niche market analysis.

To purchase your copy: http://www.rncos.com/Report/IM055.htm
For more information about the report please visit www.rncos.com


Web Site = http://www.rncos.com

Contact Details = RNCOS
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial area, Delhi 92
91-11-4214-1229
info@rncos.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •